These products have repeat prescriptions
Never, ever shake the vial
Novo Nordisk Targets Hims & Hers Compounded Semaglutide Offerings in Patent Lawsuit February 18, 2026 Caleb Harris On February 9, 2026, Novo Nordisk A/S and Novo Nordisk Inc
GLOW Blend (TB-500 + BPC-157 + GHK-Cu) Nasal Spray 70mg A multi-peptide research blend combining TB-500, BPC-157, and GHK-Cu, commonly utilized in laboratory investigations involving tissue regeneration, cellular repair mechanisms, tissue remodeling, inflammatory pathway research, and regenerative biology
By activating GLP-1 receptors, retatrutide helps stimulate insulin secretion in a glucose-dependent manner, reduces appetite, and slows gastric emptying contributing to improved blood glucose control and reduced caloric intake